Strides Pharma Science Limited announced that its step‐down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore has entered into an exclusive partnership with Ennaid Therapeutics, a global pharmaceutical company to produce an oral, repurposed medication to treat mild, moderate and asymptomatic cases of COVID‐19.
- Read more about Strides partnered with Ennaid for AI based COVID-19 medicine
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/strides-partnered-with-ennaid-for-ai-based-covid-19-medicine
No comments:
Post a Comment